Maria Taboada
Overview
Explore the profile of Maria Taboada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Taboada M, Rodriguez H, Martinez D, Pardo M, Sobrido M
Database (Oxford)
. 2014 Jun;
2014.
PMID: 24903515
Motivation: As the number of clinical reports in the peer-reviewed medical literature keeps growing, there is an increasing need for online search tools to find and analyze publications on patients...
12.
Taboada M, Alvarez V, Martinez D, Pilo B, Robinson P, Sobrido M
J Med Syst
. 2012 Oct;
36 Suppl 1:S25-36.
PMID: 23085966
The need to represent and manage time is implicit in several reasoning processes in medicine. However, this is predominantly obvious in the field of many neurodegenerative disorders, which are characterized...
13.
Taboada M, Martinez D, Pilo B, Jimenez-Escrig A, Robinson P, Sobrido M
BMC Med Inform Decis Mak
. 2012 Aug;
12:78.
PMID: 22849591
Background: Semantic Web technology can considerably catalyze translational genetics and genomics research in medicine, where the interchange of information between basic research and clinical levels becomes crucial. This exchange involves...
14.
Tomkinson H, Kemp J, Oliver S, Swaisland H, Taboada M, Morris T
BMC Clin Pharmacol
. 2011 Mar;
11:3.
PMID: 21414193
Background: Zibotentan (ZD4054) is a specific endothelin A (ETA) receptor antagonist being investigated for the treatment of prostate cancer. As zibotentan is eliminated by renal and metabolic routes, clearance may...
15.
Trump D, Payne H, Miller K, de Bono J, Stephenson 3rd J, Burris 3rd H, et al.
Prostate
. 2011 Jan;
71(12):1264-75.
PMID: 21271613
Background: This two-part study assessed the safety and tolerability of combined treatment with zibotentan (ZD4054), a specific endothelin A receptor antagonist, plus docetaxel in patients with metastatic castration-resistant prostate cancer....
16.
Dawson N, Payne H, Battersby C, Taboada M, James N
J Cancer Res Clin Oncol
. 2010 Apr;
137(1):99-113.
PMID: 20390429
Purpose: Zibotentan (ZD4054) is a specific endothelin A receptor antagonist in clinical development for the treatment of hormone-resistant prostate cancer (HRPC). In a Phase II trial in patients with pain-free...
17.
Taboada M, Lalin R, Martinez D
IEEE Trans Biomed Eng
. 2009 Mar;
56(6):1598-605.
PMID: 19272981
Nowadays, providing interoperability between different biomedical terminologies is a critical issue for efficient information sharing. One problem making interoperability difficult is the lack of automated methods simplifying the mapping process....